TGF-β1 inhibits NF-κB activity through induction of IκB-α expression in human salivary gland cells: A possible mechanism of growth suppression by TGF-β1

Experimental Cell Research

Volumn 250, Issue 1, 1999, Pages 213-222

  Azuma, Masayuki ^a   Motegi, Katsumi ^a   Aota, Keiko ^a   Yamashita, Tsuyoshi ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cell growth; I B ; NF B; Salivary gland cells; TGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; COMPLEMENTARY DNA; DNA BINDING PROTEIN; GROWTH INHIBITOR; I KAPPA B; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; GENE EXPRESSION; GENE INDUCTION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SALIVARY GLAND; SIGNAL TRANSDUCTION; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL LINE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM;

APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GROWTH INHIBITORS; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SALIVARY GLANDS; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033542506     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4503     Document Type: Article

References (59)

1. Massagué J. TGFβ signaling: Receptors, transducers, and mad proteins. Cell. 85:1996;947-950.
2. Alexandrow M. G., Moses H. L. Transforming growth factor β cell cycle regulation. Cancer Res. 55:1995;1452-1457.
3. Frey R. S., Mulder K. M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res. 57:1997;628-633.
4. 1 transition in mouse fibroblasts. Mol. Cell. Biol. 11:1991;4943-4951.
5. Ballard D., Bohnlein E., Lowenthal J., Wano Y., Franza B. R., Greene W. HTLV-1 tax induces cellular proteins that activate the κB element in the IL-2 receptor a gene. Science. 241:1988;1652-1655.
6. Cornelius P., Marlowe M., Lee M., Pekala P. Growth factor-like effects of tumor necrosis factor α J. Biol. Chem. 265:1990;20506-20516.
7. LaRosa F. A., Pierce J. W., Sonenshein G. E. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol. Cell. Biol. 14:1994;1039-1044.
8. Ji L., Arcinas M., Boxer L. M. NF-κB sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma. Mol. Cell. Biol. 14:1994;7967-7974.
9. Ghosh S., Gifford A. M., Riviere L. B., Tempst P., Nolan G. P., Baltimore D. Cloning of the p50 DNA binding subunit of NF-κB: Homology to Rel and Dorsal. Cell. 62:1990;1019-1029.
10. Ruben S. M., Dillon P. J., Schreck R., Henkel T., Chen C.-H., Maher M., Baeuerle P. A., Rosen C. A. Isolation of a Rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science. 251:1991;1490-1493.
11. Scheinman R. I., Beg A. A., Baldwin A. S. Jr. NF-κB p 100 (Lyt-10) is a component of H2F1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:1993;6089-6101.
12. Mercurio F., DiDonate J. A., Rosette C., Karin M. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:1993;705-718.
13. Siebenlist U., Franzoso G., Brown K. Structure, regulation, and function of NF-κB. Annu. Rev. Cell Biol. 10:1994;405-455.
14. Sun S.-C., Ganchi P. A., Béraud C., Ballard D. W., Greene W. C. Autoregulation of the NF-κB transactivator RelA(p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA. 91:1994;1346-1350.
15. Mellits K. H., Hay R. T., Goodbourn S. Proteolytic degradation of MAD3(IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:1993;5059-5066.
16. Beg A. A., Baldwin A. S. J. The IκB proteins: Multifunctional regulators of of Rel/NF-κB transcription factors. Genes Dev. 7:1993;1564-1570.
17. Gilmore T. D., Morin P. J. The IκB proteins: Members of a multi-functional family. Trends Genet. 9:1993;427-433.
18. Liou H. C., Baltimore D. Regulation of the NF-κB/rel transactivation factor and IκB inhibition system. Curr. Opin. Cell Biol. 5:1993;477-487.
19. Azuma M., Motegi K., Aota K., Hayashi Y., Sato M. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands. Lab. Invest. 77:1997;269-280.
20. Beauparlant P., Kwan I., Bitar R., Chou P., Koromilas A. E., Sonenberg N., Hiscott J. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation. Oncogene. 9:1994;3189-3197.
21. Visconti R., Cerutti J., Battista S., Fedele M., Trapasso F., Zeki K., Miano M. P., de Nigris F., Casalino L., Curcio F., Santoro M., Fusco A. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene. 15:1997;1987-1994.
22. Zhang Y., Feng X.-H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-fos to mediate TGF-β-induced transcription. Nature. 394:1998;909-913.
23. LeBail O., Schmidt-Ullrich R., Israël A. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: Positive regulation by members of the rel/NF-κB family. EMBO J. 12:1993;5043-5049.
24. Chiao P. J., Miyamoto S., Verma I. M. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA. 91:1994;28-32.
25. Arsura M., Wu M., Sonenshein G. E. TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκB-α Immunity. 5:1996;31-40.
26. Perella M. A., Patterson C., Tan L., Yet S.-F., Hsieh C.-M., Yoshizumi M., Lee M.-E. Suppression of interleukin-1β-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-β1 in vascular smooth muscle cells. J. Biol. Chem. 271:1996;13776-13780.
27. Sato M., Yoshida H., Hayashi Y., Miyakami K., Bando T., Yanagawa T., Yura Y., Azuma M., Ueno A. Expression of epidermal growth factor and transforming growth factor-β in a human salivary gland adenocarcinoma cell line. Cancer Res. 45:1985;6160-6167.
28. Azuma M., Tamatani T., Fukui K., Yoshida H., Kamogashira T., Ogino K., Suzuki T., Sato M. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary gland adenocarcinoma cells. Int. J. Cancer. 54:1993;669-676.
29. - mutant DNA. Lab. Invest. 69:1993;24-42.
30. Chen H., Aggarwal B. B. Role of tumor necrosis factor receptors in the activation of nuclear factor κB in human histiocytic lymphoma U-937 cells. J. Biol. Chem. 269:1994;31424-31429.
31. Claudio E., Segada F., Wrobel K., Ramos S., Bravo R., Lazo P. S. Molecular mechanism of TNFα cytotoxicity: Activation of NF-κB and nuclear translocation. Exp. Cell Res. 224:1996;63-71.
32. Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B.-M., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J.-F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α Cell. 86:1996;787-798.
33. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
34. Narayanan R., Higgins K. A., Perez J. R., Coleman T. A., Rosen C. A. Evidence for differential functions of the p50 and p65 subunits of NF-κB with a cell adhesion model. Mol. Cell. Biol. 13:1993;3802-3810.
35. Yamaguchi F., Saya H., Bruner J. M., Morrison R. S. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. USA. 91:1994;484-488.
36. Ghosh S., Baltimore D. Activation in vitro of NF-κB by phosphorylation of its inhibitor I-kappa-B. Nature. 344:1990;678-682.
37. Traenckner E. B.-M., Pahl H. L., Henkel T., Schmidt K. N., Wilk S., Baeuerle P. A. Phosphorylation of human IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:1995;2876-2883.
38. Willey J. C., Broussound A., Sleemi A., Bennett W. P., Cerutti P., Harris C. C. Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res. 51:1991;5370-5377.
39. Laiho M., DeCaprio J. A., Ludlow J. W., Livingston D. M., Massagué J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein. Cell. 62:1990;175-185.
40. Azuma M., Yuki T., Tamatani T., Motegi K., Yoshida H., Sato M. Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones. Int. J. Cancer. 66:1996;802-805.
41. Nakshatri H., Bhat-Nakshatri P., Martin D. A., Goulet R. J. Jr., Sledge G. W. Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:1997;3629-3639.
42. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
43. Cai Z., Körner M., Tarantino N., Chouaib S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J. Biol. Chem. 272:1997;96-101.
44. Sakurai H., Shigemori N., Hasegawa K., Sugita T. TGF-β-activated kinase 1 stimulates NF-κB activation by an NF-κB-inducing kinase-independent mechanism. Biochem. Biophys. Res. Commun. 243:1998;545-549.
45. Vermeer R. J., Pinedo H. M. Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin, a case report with a review of the literature. Cancer. 43:1979;1604-1606.
46. Nascimento A. G., Amaral A. L. P., Prado L. A. F., Kligerman J., Silveria T. R. P. F. Adenoid cystic carcinoma of salivary glands, a study of 61 cases with clinicopathologic correlation. Cancer. 58:1986;312-319.
47. Triozzi P. I., Brantley A., Fisher S. 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer. 59:1987;887-890.
48. Spiro R. H., Huvos A. G. Stage means more than grade in adenoid cystic carcinoma. Ann. J. Surg. 164:1992;623-628.
49. Beg A. A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
50. Liu Z.-G., Hsu H., Goeddel D. V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:1996;565-576.
51. Van Antwerp D. P., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
52. Wang C.-Y., Mayo M. W., Baldwin A. S. Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
53. Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., FitzGerald M. J., Rothstein T. L., Sherr D. H., Sonenshein G. E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
54. Azuma M., Tamatani T., Fukui K., Yuki T., Motegi K., Sato M. Different signaling pathways involved in transforming growth factor-β1-induced morphological change and type IV collagen synthesis in simian virus-40-immortalized normal human salivary gland duct and myoepithelial cell clones. Arch. Oral Biol. 41:1996;413-424.
55. Massagué J. Receptors for the TGF-β family. Cell. 69:1992;1067-1070.
56. Yingling J. M., Datto M. B., Wong C., Frederick J. P., Liberati N. T., Wang X.-F. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17:1997;7019-7028.
57. Kang S. M., Tran A. C., Grilli M., Lenardo M. J. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science. 256:1992;1452-1456.
58. Franzoso G., Bours V., Azaenko V., Park S., Tomita-Yamaguchi M., Kanno T., Brown K., Siebenlist U. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J. 12:1993;3893-3901.
59. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia-telangiectasia cells by a truncated IκBα Science. 268:1995;1619-1621.